1.      Safarpour MM, Haghpanah S, Meshksar A, Karimi M. Phenotype Report on Turk J Haematol. 2017 Aug 2;34(3):250-253.
2.      Haghpanah S, Vahdati S, Karimi M. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran. Hemoglobin. 2017 Jul 25:1-6.
3.      Erjaee A, Niknam M, Sadeghi A, Karimi M, et al. A significant breakthrough in the incidence of childhood cancers and evaluation of its risk factors in Southern Iran. Indian Journal of Medical and Paediatric Oncology.2017 APR-JUN; 38(2):158-164.
4.      Klei TRL, Kheradmand Kia S, Veldthuis , Beuger BM, Geissler J, Dehbozorgian J, Karimi M, et al. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia. Eur J Haematol. 2017 Jun;98(6):584-589.

5.      De Sanctis V, Kattamis C, Canatan D, Soliman AT, Elsedfy H, Karimi M, et al. β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint. Mediterr J Hematol Infect Dis. 2017 Feb 20;9(1):e2017018.

6.      Kavakli K, Demartis F, Karimi M, Eshghi P. Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study. Haemophilia. 2017 Jul;23(4):575-582.
7.      Haghpanah S, Vahdati S, Karimi M. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran. Hemoglobin. 2017 Jul 25:1-6.
8.      Tahmasbi L, Karimi M, Kafiabadi SA, Nikougoftar M, Haghpanah S, Ranjbaran R, Moghadam M.Evaluation of Plasma Platelet Microparticles in Thrombotic Thrombocytopenic Purpura.Ann Clin Lab Sci. 2017 Jan;47(1):62-67.
9.      Karimi M, Zarei T, Haghpanah S, Moghadam M, et al. Relationship Between Some Single-nucleotide Polymorphism and Response to Hydroxyurea Therapy in Iranian Patients With β-Thalassemia Intermedia. J Pediatr Hematol Oncol. J Pediatr Hematol Oncol. 2017 May;39(4):e171-e176.
10. Cannavò A, Valsecchi C, Garagiola I2, Palla R, Mannucci PM1, Rosendaal FR, Peyvandi F,karimi m, SIPPET study group. Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A. Blood. 2017 Mar 9;129(10):1245-1250.
11. Amoozgar H, Zeighami S, Haghpanah S, Karimi M. A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major. Hematology. 2017 Jan;22(1):25-29.
12. Karimi M, Haghighat M, Dialameh Z, Tahmasbi L, Parand S, Bardestani M. Breastfeeding as a Protective Effect Against Childhood Leukemia and Lymphoma. Iran Red Crescent Med J. 2016 Feb 13;18(9):e29771.
13. Naderi M, Karimi M, Hosseini MSet al. Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P. Iran J Pharm Res. 2016 Spring;15(2):635-40.
14. Seyedifar M, Abedin FD, Hamidieh AA, Nader M, Karimi M, et al. Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran. Int J Hematol Oncol Stem Cell Res. 2016 Oct 1; 10(4):224-231.
15. Beheshtipoor N, Ghanavati S, Edraki M, Karimi M, Haghpanah S. Hemoaction Game: An educational Step to Improve Hemophilia Children and Nurses Self-Efficacy. J Adv Med Educ Prof. 2016 Oct;4(4):206.
16. Karimi M, Avazpoor A, Haghpanah S, et al. Evaluation of proteinuria in B-thalassemia major patients with and without diabetes mellitus taking Deferasirox. J Pediatr Hematol Oncol. 2017 Jan;39(1):e11-e 
17. 14.Zarei T, Dehbozorgian J, Imanifard J, Setoodegan F, Karimi M. A Number of Cases in Iran Presenting with Coinheritance of Hb H Disease and β-Thalassemia Minor Hemoglobin. 2016 Sep;40(5):316-318
18. Napolitano M, Di Minno MN, Batorova A, Dolce A, Karimi M, Mariani G, et al.Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.Haemophilia. 2016 Sep;22(5):752-9.
19. Karimi M, Abdulkarimi B, Naderi M, Parand S. Aquired Hemophilia:A report of 4 cases. Ann Hematol Oncol. 2016; 3(1): 1074.
20. Haghpanah S, Mohtadi H, Akbari M, Karimi M.Quality of Life in Children and Adolescents with Rare Bleeding Disorders in Southern Iran.Clin Appl Thromb Hemost. 2016 Feb 22. Pii: 1076029616634887. [Epub ahead of print]
21. De Sanctis V, Soliman AT, Elsedfy H, Albu A, Al Jaouni S5, El Kholy M, Karimi M, et al. The ICET-A Survey on Current Criteria Used by Clinicians for the Assessment of Central Adrenal Insufficiency in Thalassemia: Analysis of Results and Recommendations. Mediterr J Hematol Infect Dis. 2016 Jul 1;8(1):e2016034.
22. Peyvandi F, Mannucci PM, Garagiola I, Eshghi P, Karimi M, et al. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A. N Engl J Med. 2016 May 26;374(21):2054-64.
23. Zarei T, Haghpanah S, Parand S, Karimi M, et al. Evaluation of bone mineral density in patients with hemoglobin H disease. Ann Hematol. 2016 Aug; 95(8):1329-32.
24. Karimi M, Haghpanah S, Pishdad P, Rachmilewitz EA. Frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major compared to healthy individuals. Ann Hematol. 2016 Aug; 95(8):1387.
25. Karimi M, Jooya P, Haghpanah S, et al. Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients. Hemoglobin. 2016 Aug; 40(4):250-6.
26. De Sanctis V, Elsedfy H, Soliman AT, Elhakim IZ, Soliman NA, Karimi M, Elalaily R. The Diagnostic Approach to Central Adrenocortical Insufficiency (CAI) in Thalassemia. Mediterr J Hematol Infect Dis. 2016 May 1; 8(1):e2016026.
27. Shahriari M, Bazrafshan A, Moghadam M, Karimi M. Severe hemophilia in a girl infant with mosaic Turner syndrome and persistent hyperplastic primary vitreous. Blood Coagul Fibrinolysis. 2016 Apr; 27(3):352-3
28. Karimi M, Tavoosi H, Haghpanah S, Ardeshiri R, et al. Efficacy and safety of factor eight inhibitor bypassing activity prophylaxis evaluation in young patients with hemophilia and high titer inhibitor. Blood Coagul Fibrinolysis. Blood Coagul Fibrinolysis. 2016 Mar; 27(2):232-3.
29. Karimi M, Toosi F, Haghpanah S, et al. The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major. Ann Hematol. Ann Hematol. 2016 Jan; 95(1):135-9.
30. Moghadam M, Karimi M, Dehghani SJ, Dehbozorgian, et al. Effectiveness of β-thalassemia prenatal diagnosis in Southern Iran: a cohort study. Prenat Diagn. 2015 Dec; 35(12):1238-42.
31. Tasbihi M, Pishadad P, Haghpanah S, Ardeshiri R, Tavoosi H, Karimi M. A comparison between MRI, sonography and Functional Independence Score in Haemophilia methods in diagnosis, evaluation and classification of arthropathy in severe haemophilia A and B. Blood Coagul Fibrinolysis. Blood Coagul Fibrinolysis. 2016 Mar; 27(2):131-5.
32. Haghpanah S, Bazrafshan A, Karimi M, et al. Evaluation of Thrombin Generation Assay in Patients with Hemophilia. Clin Appl Thromb Hemost. 2016 May;22(4):322-6.
33. Beheshtipour N, Nasirpour P, Yektatalab S, Karimi M, Zare N. The Effect of Educational-Spiritual Intervention on the Burnout of the Parents of School Age Children with Cancer: A Randomized Controlled Clinical Trial. Int J Community Based Nurs Midwifery. 2016 Jan; 4(1):90-7.
34. Rahimi R, Foroughi AA, Haghpanah S, Bahmanyar M, Jelodari S, De Sanctis V, Karimi M. Incidence of testicular microlithiasis in patients with β-thalassemia major. Ann Hematol. 2015 Nov; 94(11):1785-9.
35. Napolitano M, Dolce A, Batorova A, Karimi M, et al. Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery. Haemophilia. 2015 Nov; 21(6):e513-7.
36. Geramizadeh B, Khademi B, Karimi M, Shekarkhar G. Infantile fibrosarcoma of ethmoid sinus, misdiagnosed as an adenoid in a 5-year-old child. J Oral Maxillofac Pathol. 2015 May-Aug; 19(2):271.
37. Bordbar MR, Bazrafshan A, Karimi M. Successful Management of Vinblastin Overdose with Exchange Transfusion: A Case Report. Iran J Ped Hematol Oncol. 2015; 5(2):113-5.
38. Haghpanah S, Esmaeilzadeh M, Karimi M, et al. Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran. Iranian Red Crescent Medical Journal. 2015 Jul 7(7): e28343.
39. Karimi M, Arandi N, Haghpanah S, Ansari S, Azarkeyvan A, Bordbar M, Safaei S. Efficacy of Deferasirox (Exjade [1] ) in Modulation of Iron Overload in Patients with b-Thalassemia Intermedia. Hemoglobin. 2015 Jun 26:1-3.
40. Amoozgar H, Dastgheib L, Seifi V, Karimi M. Evaluation of cardiac sequelae in patients with sickle cell anemia. HELLENIC JOURNAL OF CARDIOLOGY.2015 MAY-JUN . 56  ( 3 ) 242-246
41. Beheshtipoor N, Ghanavati Sh, Edraki M, Karimi M, Haghpanah S. The Effects of Computer-based Educational Games on Self-efficacy of 8-12 Children with Hemophilia. IJBC 2015; 7(3): 157-162.
42. De Sanctis V, Soliman A, Elsedfy H, Karimi M, Cohan N. et al. Medical care and transition phase of thalassemia in different countries: the ICET-An experience. Rivista Italiana di Medicina dell’Adolescenza. 2015, Suppl. 1, 13(2):5-16
43. De Sanctis V, Soliman A, Elsedfy H, Karimi M, Cohan N. et al. De Sanctis V, Soliman A, Elsedfy H, Karimi M, Cohan N. et al. General principles of good transition care: a short review of the literature Rivista Italiana di Medicina dell’Adolescenza. 2015, Suppl. 1, 13(2):5-10.
44. Majd Z, Haghpanah S, Matin S, Karimi M, et al.  Correlation of serum ferritin levels with heart and liver MRI and LIC in transfusion dependent thalassemia patients. IRCMJ2015 Apr; 17(4): e24959.
45. Zareifar S , Karimi M , Tasbihi M , Abdolkarimi B, et al. Pleuropulmonary blastoma is a rare malignancy in young adult and childhood. Korean Journal of Clinical Oncology 2015; 11:28-32.
46. Karimi M, Cohan N, Parand Sh. Thalassemia and Women’s Health. Women's Health Bulletin. 2015 July; 2(3): e29440.
47. Beheshtipoor N, Bagheri SH, Karimi M, et al. The Effect of Yoga on the Quality of Life in the Children and Adolescents with Haemophilia. IJCBNM Apr.2015; Vol 3, No 2
48. Karimi M, Haghpanah S. The Effects of Economic Sanctions on Disease Specific Clinical Outcomes of Patients with Thalassemia and Hemophilia in Iran. Health Policy. 2015 Feb; 119(2):239-43.
49. Dehbozorgian M, Moghadam M, Karimi M, Haghpanah S, et al. Distribution of α-thalassemia mutations in Iranian population. Hematology. 2015 Jul; 20(6):359-62.
50. Arandi N, Haghpanah S, Taher AT, Karimi M, et al. Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources. Transfus Med. 2015 Feb; 25(1):8-12.
51. Matin S, Haghpanah S, De Sanctis V, et al. The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran. Mediterr J Hematol Infect Dis. 2015 Jan 1; 7(1):e2015005.
52. Karimi M, Cohan N, Pishdad P. Hydroxyurea as a first line treatment of extramedullary hematopoiesis in patients with beta thalassemia, four case reports. Hematology. 2015 Jan; 20(1):53-7.
53. Abolhasani Foroughi A , Ghaffari  H , Haghpanah S, Karimi M, et al. Comparative Study of Radiographic and Laboratory Findings Between Beta Thalassemia Major and Beta Thalassemia Intermedia Patients With and Without Treatment by Hydroxyurea. Iranian Red Crescent Medical Journal. 2015 February; 17(2): e23607.
54. De Sanctis V , Al Jaouni S , Elsedfy H , Karimi M, et al. Selected Highlights of the IX International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, and Endocrine Complications in Thalassaemia.Rivista Italiana di Medicina dell’Adolescenza. 2015; 13(1):1-14.
55. De Jager T1, Pericleous L, Kokot-Kierepa M, Naderi M, Karimi M. The burden and management of FXIII deficiency. Haemophilia. 2014 Nov; 20(6):733-40.
56. Karimi M, Cairo A, Safarpour MM, Haghpanah S, et al. Genotype and phenotype report on patients with combined deficiency of factor V and factor VIII in Iran. Blood Coagul Fibrinolysis. 2014 Jun; 25(4):360-3.
57. Musallam KM, Cappellini MD, Daar S, Karimi M, et al.  Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study. Haematologica. 2014 Nov; 99(11):e218-21.
58. Shahriari M, Haghapanh S, Karimi M, et al. Serum cancer antigen 15.3 concentrations in patients with beta-thalassemia minor compared to those with cancer and healthy in-dividuals. Med J Islam Repub Iran. 2014 Sep 13; 28:91. ECollection 2014.
59. Pasalar M, Mehrabani D,, Karimi M. et al. Prevalence of thalassaemia, iron-deficiency anaemia and glucose-6-phosphate dehydrogenase deficiency among Arab migrating nomad children, southern Islamic Republic of Iran. East Mediterr Health J. 2014 Dec 17; 20(11):726-31.
60. Faranoush M, Abolghasemi H, Toogeh G, Karimi M, et al. A Comparison between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients with Congenital Factor VII Deficiency. Clin Appl Thromb Hemost. 2015 Nov; 21(8):724-8.
61. Faranoush M1, Abolghasemi H, Mahboudi F, Toogeh G, Karimi M, Eshghi P, et al. A Comparison of Efficacy between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients with Hereditary FVIII Deficiency with Inhibitor. Clin Appl Thromb Hemost. 2014 Oct 24. [Epub ahead of print]
62. De Sanctis V, Soliman AT, Karimi M, et al. Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major. Mediterr J Hematol Infect Dis 2014; 6; 1-10.
63. Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A. Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014 Oct; 31(7):583-96.
64. Haghpanah S, Ramzi M, Zakerinia M, Karimi M, et al. Epidemiology of Hemoglobinopathies and Thalassemias in Individuals Referred to the Haematology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran From 2006 to 2011. Hemoglobin. Hemoglobin. 2014; 38(4):287-8.
65. Bordbar M, Haghpanah S, Karimi M, et al. Hydroxyurea treatment in transfusion dependent beta thalassemia patients. Iran Red Crescent Med J. 2014; 16(6):e18028
66. Khavari M, Hamidi A, Haghpanah S, et al. Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea. Iran Red Crescent Med J. 2014 Jul; 16(7):e18712.
67. Honar N, Karimi M. et al. Frequency of Celiac Disease in Children with Beta Thalassemia major. Iranian Journal of Pediatric Hematology Oncology2014; 4(2):48-52.      
68. Shakibazad N   , Karimi M. Rhabdomyosarcoma of Eyelid:  A picture presentation. IJBC 2014; 6(3): 221-222.
69. Haghpanah S, Zarei T, Zahedi Z, Karimi M. Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia. Hematology. 2014 Jun; 19(4):187-91.
70. Naderi M, zarei T, Karimi M, et al. Intracranial hemorrhage pattern in the patients with Factor XIII deficiency. Ann Hematol. 2014 Apr; 93(4):693-7.
71. Batorova A1, Mariani G, Kavakli K, de Saez AR, Caliskan U, Karimi M,et al. Inhibitors to factor VII in congenital factor VII deficiency. Haemophilia. 2014 Mar; 20(2):e188-91.
72. Golafshan HA, Karimi M, Sharifzadeh S. et al. Evaluation of red cell membrane cytoskeletal disorders using a flow cytometric method in South Iran. Turk J Hematol. 2014 Mar; 31 (1):25-31
73. Haghpanah S, Karimi M, et al. An experience of using Traumastem P in control of spontaneous nose bleeding in patients with inherited bleeding disorders in southern Iran. Haemophilia. 2014 Jan; 20(1):e79-80.
74. Zekavat OR, Makarem AR, Haghpanah S, Karimi M. Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea. Iran J Med Sci. 2014 Jan; 39(1):60-3.
75. De Sanctis V1, Soliman AT2, Elsedfy H3, Karimi M, et al. Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. Pediatr Endocrinol Rev. 2013 Dec; 11(2):167-80.
76. Parand F, Honar N, Aflaki Kh, Karimi M, et al. Management of bleeding in post-liver disease, surgery and biopsy in patients with high uncorrected international normalized ratio with prothrombin complex concentrate - an Iranian experience. IRCMJ, 2013 December; 15(12): e12260
77. Parand A, Karimi M, et al. Inherited Thrombophilia and Recurrent Pregnancy Loss. IRCMJ. 2013 Dec. 15(12): e13708
78. Keshtkaran A, Javanbakht M, Karimi M. et al. Cost-utility analysis of oral deferasirox versus infusion defereoxamine in transfusion-dependent B-thalassemia patients. Transfusion. 2013 Aug;53 (8):1722-9
79. Zekavat OR, Haghpanah S, Dehghani J, Afrasiabi A, Peyvandi F, Karimi M. Comparison of Thrombin Generation Assay With Conventional Coagulation Tests in Evaluation of Bleeding Risk in Patients With Rare Bleeding Disorders. Clin Appl Thromb Hemost. 2013 Feb 6; 20(6):637-644
80. Karimi M, Jenabali Jahromi B, De Sanctis V, et al. Prevalence of ovarian cysts in female patients with beta-thalassemia major in Fars province, South Iran. Rivista Italiana di Medicina dell’Adolescenza. 2013; 11(2): 61-5.
81. Zarei T, Haghpanah S, Karimi M, et al. Frequency of ovarian cyst in women with beta-thalassemia intermedia in Southern Iran. Rivista Italiana di Medicina dell’Adolescenza. 2013; 11(3): 35-37.
82. Soliman A., De Sanctis V., elsedfy H , Karimi M, et al. Growth hormon deficiency in adults with thalassemia: An overview and the I-CET recommendations. Georgian Medical news. 2013; 9 (222): 79-84.
83. Zekavat O.R., Geramizadeh B., Makarem A., Karimi M. Multiple subcutaneous nodules as a rare presentation of alveolar rhabdomyosarcoma. Eur. J. Pediat. Dermatol. 2013; 23, 78-82.
84. Haghpanah S, Nasirabadi S, Ghaffarpasand F, Karami R, Mahmoodi M, Parand S, Karimi M. Quality of life among Iranian patients with beta-thalassemia major is using the SF-36 questionnaire. Sao Paulo Med J. 2013; 131(3):166-72.
85. Naderi M, Eshghi P, Cohan N, Haghpanah S, Karimi M. Evaluation of the FXIII deficiency prophylaxis intervals in large number of FXIII deficiency patients from Iran. Haemophilia. 2013; 19: e174-e192
86. Bagheri S, Beheshtipoor N, Rambod M, Karimi M, Zare N, Hashemi F. The quality of life of children with hemophilia in Shiraz, Iran. IJCBNM. 2013; 1(2): 110-120.
87. Mariani G, Napolitano M, Dolce A, Pérez Garrido R, Batorova A, Karimi M, et al. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation. Thromb Haemost. 2013 Feb; 109(2):238-47.
88. Haghpanah S, Karimi M. Frequency of combined factor V and factor VIII deficiency in southern Iran. Blood Coagul Fibrinolysis. 2013; 24(4):458-9.
89. Saki F., Bordbar MR, Karimi M, et al. Diffuse Hepatic Calcifications in a Transfusion-Dependent Patient with Beta-Thalassemia: A Case Report. Iran J Med Sci Sep. 2013; 38 (3):271-74.
90. Haghpanah S, Ardeshiri R, Zahedi Z, Karimi M, et al. Attitudes and practices with regard to circumcision in haemophilia patients in Southern Iran. Haemophilia. 2013 May; 19(3):e177-8.
91. Tabei SM, Mazloom M, Shahriari M, Zareifar S, Azimi A, Hadaegh A, Karimi M. Determining and Surveying the Role of Carnitine and Folic Acid to Decrease Fatigue in β-Thalassemia Minor Subjects. Pediatr Hematol Oncol. 2013 Nov; 30(8):742-7.
92. Bordbar MR., Zareifars S, Karimi M, et al. Unusual Presentation of  T-cell  non-Hodgkin Lymphoma with Multiple Skin Nodules. IJBC 2013; 4: 179-181
93. Hashemi F, Sedghi M, Karimi M. The impact of educating parents of leukaemic children on the healthy siblings' quality of life. Journal of the Pakistan medical assosciation. 2013; 63(2):  249-252. 
94. Shariat A , Nazeri M, Karimi M, et al. Transcranial Doppler Ultrasonography in Beta-thalassemia Major Patients Without and With Thrombocytosis. Iran Red Crescent Med J. 2013; 15(3).
95. Saffari B, Senemar S, Karimi M, et al. An MTHFR Variant, Plasma Homocysteine Levels and Late-Onset Coronary Artery Disease in Subjects from Southern Iran. Pakistan Journal of Biological Sciences. 2013; 16(16): 788-795.
96. Hamidian Jahromi A, Karimi M. DDAVP might reduce the risk of preeclampsia in pregnant women with VWF deficiency. Turk J Hematol 2013; 30: 214-215
97. Haghpanah S, Karimi M, Bordbar M, Kamfiroozi R, Asgharzadeh H. Experience on Using Prothrombin Complex Concentrate in Urgent Warfarin Reversal: An Iranian Survey. Clin Appl Thromb Hemost. 2013 Jun; 19(3):277-81
98. Haghpanah S, Johari S, Parand S, Bordbar MR, Karimi M. Family Planning Practices in Families with Children Affected by β-Thalassemia Major in Southern Iran. Hemoglobin. 2013; 37(1): 74–79.
99. Karimi M, Haghpanah S, Ashjazadeh N. Cerebral Artery Velocity Determined by Transcranial Doppler Ultrasonography in Patients With β-Thalassemia Intermedia Compared to β-Thalassemia Major. Clin Appl Thromb Hemost. 2013 Jul; 19(4):367-73.
100.Musallam KM, Taher AT, Karimi M, Rachmilewitz EA. Cerebral infarction in β-thalassemia intermedia: Breaking the silence. Thromb Res. 2012; 130: 695–70.
101.Van Geffen M, Menegatti M, Loof A, Lap P, Karimi M, et al. Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders. Haemophilia. 2012 Jul; 18(4):630-8.
102.Karimi M, Haghpanah S, Taher AT, Cappellini MD. Β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life. Anemia. 2012:902067.
103.Karimi M, Haghpanah S, Bagheri MH, et al. Frequency and distribution of asymptomatic brain lesions in patients with beta-thalassemia intermedia. Ann Hematol. 2012; 91:1833–1838.
104.Karimi M, Azarkeivan A, Zareifar S, et al. Iranian experience of deferasirox (Exjade®) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels? Hematology 2012; 17 (6):367-71.
105.Haghpanah S, Nasirabadi S, Rahimi N, Faramarzi H, Karimi M. Sociocultural challenges of beta-thalassaemia major birth in carriers of beta-thalassaemia in Iran. J Med Screen. 2012; 19(3):109-11.
106.Bordbar MR, Taj-Aldini R, Haghpanah S, Karimi M, et al.Thyroid function and stress hormones in children with stress hyperglycemia. Endocrine. 2012 Dec; 42(3):653-7.
107.Ashjazadeh N, Emami S, Petramfar P, Yaghoubi E, Karimi M. Intracranial Blood Flow Velocity in Patients with β-Thalassemia Intermedia Using Transcranial Doppler Sonography: A Case-Control Study. Anemia. 2012:798296.
108.Naderi M, Eshghi P, Cohan N, Karimi M et al. Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran. Haemophilia. 2012 Sep; 18(5):773-776.
109.Karimi M, Emad Marvasti V , Karamifar H, et al. Prevalence of gynecomastia in blood transfusion beta thalassemia major adolescent boys. Rivista Italiana di Medicina dell’Adolescenza. 2012; 10(3): 101-4
110.Karimi M, Marvasti VE, et al. Prevalence of Delta Beta Thalassemia Minor in Southern Iran. IJBC 2012; 4: 153-155.
111.Bazrgar M, Karimi M. Is the apolipoprotein E4 allele always hazardous?
Serum uric acid level as a conflict. Genet Test Mol Biomarkers. 2012 Aug; 16(8):920-3.
112.Haghpanah S, Nasirabadi Sh, Karimi M, et al. Polymorphisms Associated with Sickle Cell Disease in Southern Iran. Russian Journal of Genetics. 2012; 48:755–757.
113.Taher AT, Musallam KM, Karimi M, Cappellini MD. Contemporary approaches to treatment of beta-thalassemia intermedia. Blood Rev. 2012 Apr; 26 Suppl 1:S24-7.
114.Bordbar M, Haghpanah S, Afrasiabi A, Dehbozorgian J, Karimi M. Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran. J Clin Lipidol. 2012 Mar; 6(2):108-13.
115.Karimi M, Zekavat OR, Haghpanah S, Javad P, Karamizadeh Z. Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea. Hematology. 2012 Mar; 17(2):122-4.
116.De Sanctis V, Elawwa A, Angastiniotis M, Eleftheriou A, Kattamis C, Karimi M, El Kholy M, Elsedfy H, Yassin MA, Fiscina B, Soliman AT. Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha, (October 2-3, 2011). Pediatr Endocrinol Rev. 2012 Mar; 9(3):672-9.
117.Mehramiri A, Parand S, Haghpanah S, Karimi M. Attitudes of haemophilic patients towards their health and socio-economic problems in Iran. Haemophilia. 2012 Jan; 18(1):122-8.
118.Rashid M, Karimi M. Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran. Transfus Med. 2012 Apr; 22(2):104-7
119.Karimi M, Haghpanah S, Farhadi A, Yavarian M. Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. Int J Hematol. 2012 Jan; 95(1):51-6.
120.Karimi M. Hydroxyurea therapy in thalassemia. TIF magazine. 2012
121.Eshghi P, Cohan N, Lak M, Naderi M, Peyvandi F, Menegatti M, Karimi M. Arg77His and Trp187Arg are the Most Common Mutations Causing FXIII Deficiency in Iran. Clin Appl Thromb Hemost. 2012 Jan-Feb; 18(1):100-3.
122.Haghpanah S, Karimi M. Cerebral thrombosis in patients with β-thalassemia: a systematic review. Blood Coagul Fibrinolysis. 2012 Apr; 23(3):212-7.
123.Dehghani SJ, Amiri Dashtarzhen A, Karimi M, et al. Combined α-thalassemia and Hemoglobin J-Iran (β77 His → Asp). A Family Study in southern Iran. Iran Red Crescent Med J. 2011 Aug; 13(8):586-9.
124.De Sanctis V, Soliman AT, Angastiniotis M, Eleftheriou A, Kattamis Ch, Karimi M, et al. International network on endocrine complications in thalassaemia (I-CET): an opportunity to grow. Georgian Med News. 2012 Apr ;( 205):52-7.
125.Karimi M, Vafafar A, Haghpanah S, et al. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran. Haemophilia. 2012 Mar; 18(2):2011-215.
126.Bastani P, Pourmohamadi K, Karimi M. Quality of life in hemophilia complicated by inhibitors. Iran Red Crescent Med J. 2012 Apr; 14(4):250-1.
127.Karimi M,  Emadmarvasti  V, Hoseini J,  Shoja L. Major Causes of Hospital Admission in Beta Thalassemia Major Patients in Southern Iran. IJP. 2011; 21(4): 509-513.
128.Cohan N, Karimi M. Diagnosis and Management of von Willebrand Disease in Iran. SEMIN THROMB HEMOST. 2011; (5):602-13.
129.Karimi M & Cohan N. B-thalassemia Intermedia, a review of literature. IJBC. 2011; 4:179-187.
130.Rasekh HR, Imani A, Karimi M, Golestani M. Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran. Clinicoecon Outcomes Res. 2011; 3:207-12.
131.Kiadaliri A, Bastani P, Karimi M, et al. The Impact of Factor VIII Inhibitors on Factor Consumption in Haemophilia A: A Case-Control Study in South of Iran. Middle East Journal of Scientific Research. 2011; 8(3): 694-98.
132.Karimi M, Musallam Kh, Cappellini M, taher A, et al. Risk factors for pulmonary hypertension in patients with β thalassemia intermedia. European Journal of Internal Medicine.  2011; 22: 607–610.
133.Pishva N, Afrasiabi A, Shahbazi  MR, Karimi M, Haghpanah S. Protein C concentration in newborn infants with sepsis-like illness. Journal of Neonatal-Perinatal Medicine 4 (2011) 55–58.
134.Hashemi F, Asadi N, Beheshtipour N, Karimi M. The Impact of Educating Parents of Leukemic Children on the Patients’Quality of Life. Iran Red Crescent Med J. 2011; 13(8):553-7.
135.Basiratnia M, Yavarian M, Karimi M, et al. Non-Hodgkin Lymphoma in a Child with Schimke Immuno-Osseous Dysplasia. Iran J Med Sci September 2011; 36
136.Amoozgar H, Farhani N, Karimi M.  Risk factors for pulmonary hypertension in patients with thalassemia intermedia. European Journal of Haematology. 2011; 85:549-551
137.Karimi M, Ravanbod S, Cohan N, Ala F. How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries. Haemophilia. 2011 Jul; 17 Suppl 1:42-4.
138.Haghpanah S, Vafafar M, Karimi M, et al. Use of Glubran 2 and Glubran tissue skin adhesive in patients with hereditary bleeding disorders undergoing circumcision and dental extraction. Ann Hematol. 2011; 90:463-468.
139.Amoozgar H, Farhani N, Khodadadi N, Karimi M, Cheriki S. Comparative study of pulmonary circulation and myocardial function in patients with β-thalassemia intermedia with and without hydroxyurea, a case-control study. Eur J Haematol. 2011 Jul; 87(1):61-7.
140.Amoozgar H, Farhani N, Karimi M. Early echocardiographic findings in b-thalassemia intermedia patients using standard and tissue Doppler methods. Pediatr Cardiol. 2011; 32:154-159.
141.Cohan N, Sarikhani S, Moslemi S, Karimi M. Initial presentation of acute lymphoblastic leukemia with osteoporosis and multiple spontaneous bone fractures. Iran Red Crescent Med J 2011:13(1):52-54
142.Karimi M, Emad Marvasti V, Imanieh MH, Jahaniar Moqadam F. Amantadine plus interreron-a versus interferon-a monotherapy for the treatment of chronic hepatitis C infection in b-thalassemia major patients: a randomized double blinded pilot study in Shiraz, Iran. Iranian Journal of Blood and Cancer Vol 2 No 1 Autumn 2009, 19-23
143.Shamsakhzari Sh, Afrasiabi AB, Haghpanah S, Karimi M. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease in southern Iran. Blood Coagul Fibrinolysis. 2011 Jun; 22(4):325-30.
144.Jenabali Jahromi B, Karimi M. Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency. Haemophilia 2011; 17, 703–20.
145.Rezaeifarid M, Soveid M, Ghaemi S, Karimi M.  Bone mineral density in Iranian patients with hemophilia: the first experience in southern Iran. Haemophilia. 2011 May; 17(3):552-3.
146.Haghpanah S, Sahraiian M, Afrasiabi A.R, Enayati S, Karimi M. The correlation between gene mutations and inhibitor development in patients with hemophilia A in southern Iran. Haemophilia 2011; 17:815-829.
147.Rezazadeh S, Haghighat A, Mahmoodi M, Babanezhad Z, Karimi M. Synoviorthesis induced by Rifampicin in hemophilic arthropathy; Report of 24 treated joints. Annals of Hematology. 2011, 90:963–969.
148.Alyasin S, Moghtaderi M, Karimi M, et al. Pulmonary function test in transfusion-dependent β-thalassemia major patients: a pilot study. Pediatr Hematol Oncol. 2011 May; 28(4):329-33.
149.Yavarian M, Cohan N, Karimi M, et al. Impact of Iron deficiency anaemia on HbA2 levels. Journal of Appplied Hematology. 2011; 200-2.
150.Mahmoodi M, Peyvandi F, Afrasiabi A.R, Ghaffarpasand F, Karimi M. Bleeding Symptoms in Heterozygous Carriers of Inherited Coagulation Disorders in Southern Iran. Blood Coagulation and Fybrynolyisis. 2011, Vol 22 No 5.
151.Yavarian M, Ramzi M, karimi M, et al. Impact of inherited thrombophilic factors on deep vein thrombosis in individuals in south Iran. Journal of Applied Hematology 2011, 15-19.
152.Mahdavi MR, Karimi M, Yavarian M, et al. Detection of Hb Setif in north Iran and the question of its origin: Iranian or multiethnic? Hemoglobin. 2011;35(2):152-6.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
153.Hassanzadeh J, Mohammadi R, Rajaeefard A.R, Bordbar M.R, Karimi M. Maternal and Prenatal Risk Factors for Childhood Leukemia in Southern of Iran. IRCMJ 2011; 13(6):1-6.
154.Mahmoodi M, De Sanctis V, Karimi M. Diffuse Intracerebral Calcification in a Beta-Thalassaemia Major Patient withHypoparathyroidism: A Case Report. Pediatric Endocrinology Reviews 2011; 8 (Sup 2):331-3.
155.Amooee S, Samsami A, Jahanbakhsh J, Karimi M. The pregnancy outcome in patients with minor beta-thalassemia. IJRM 2011; 9(1): 9-14.
156.De Sanctis V, Giovannini M, Ciccone S, Karimi M. Generalized Tonic-Clonic Seizure in a Thalassemic Patient with Hypoparathyroidism and Brain Calcinosis. Pediatric 
157.Endocrinology Reviews 2011; 8(sup 2):334-6.
158.Mahjour SB, Ghaffarpasand F, Fattahi MJ, Ghaderi A, Fotouhi Ghiam A, Karimi M. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in Southern Iran. Pathol. Oncol. Res. (2010) 16:579-582
159.Bazrgar M, Peiravian F, Abedpour F, Karimi M. Causes for hospitalization and death in Iranian patients with β-thalassemia major. Pediatr Hematol Oncol. 2011 Mar; 28(2):134-9.
160.Shahriari M, Bordbar M.R, Geramizadeh B, Karimi M. Leukemic infiltration of the appendix as an unusal site of extramedulary relapse: reportof of two cases and review of the literature. IJMS Vol 35, Sep. 2010
161.Karimi M, Mehrabani D, Pasalar M, Afrasiabi AR, Mehravar Z, et al. Thalassemia, iron and G6PD deficiency in lor migrating nomad children, Southern Iran. IRCMJ 2010;12(4):441-445
162.De Sanctis V, Ciccone S, Karimi M. Generalized tonic-clonic seizures in a thalassemic patient with hypoparathyroidism and brain calcinosis. Rivista Italian di Medicina dell' Adolescenza -  Volume 8, n. 2, 2010
163.Faramarzi A, Karimi M, Heydari S.T, et al. Frequency of sensory neural hearing loss in major beta-thalassemias in Southern Iran. Iran J Pediatr, Sep 2010;Vol 20 (No 3), 308-312
164.Karimi M, Khanlari M, Rachmilewits EA. Erratum: "Cerebrovascular accident in b-thalassemia major (b-TM) and b-thalassemia intermedia (b-TI)" by Karimi et al. Am J Hematol 83:77-79, 2008, DOI number 20938. Am J Hematol. 2010 Sep 14.
165.Taher AT, Masullam KM, Karimi M, et al. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost. 2010; Jun 7.
166.Taher AT, Musallam KM, El-Beshlawy A, Karimi M, et al. Age-related complications in treatment-naïve patients with thalassemia intermedia. Br J Haematol. 2010Aug; 150(4):486-9.
167.Haghpanah S, Davani M, Samadi B, Ashrafi A, Karimi M. Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran. JRMS/May & June 2010;Vol 15, No 3
168.Karimi M, Emad Marvasti V, Rasekhi A, et al. MRI evaluation of liver iron concentration in patients with β-thalassemia major. Hepatitis Monthly 2010; 10(2):149-150.
169.Karimi M, Cohan N. Cancer-associated thrombosis. The Open Cardiovascular Medicine Journal, 2010, 4, 59-63.
170.Karimi M, Bagheri H, Rastgu F, et al. Magnetic resonance imaging to determine the incidence of brain ischemia in patients with β-thalassemia intermedia. Thrombosis and Haemostasis 103.5/2010
171.Akbari A, Dehbozorgian J, Afrasiabi A.R., Gafari H, Gerdabi J, Karimi M. Frequnecy of afterload homocysteinemia in normal population of southern Iran: A pilot study. Pakistan Journal of Biological Sciences 13(7):352-354,2010
172.Zareifar S, Bordbar MR, Karimi M, Geramizadeh B, Rasekhi AR. T-cell lymphoblastic lymphoma of the sternum. J Clin Oncol. 2010 Feb 1; 28(4):e51-3.
173.Fotouhi Ghiam A, Hashemi A, Taban S, Bordbar M.R, Karimi M. Beta thalassemia minor as a risk factor for suicide and violence: A failure to replicate. Pshychology, 2010,1:17-21
174.Eshghi P, Mahdavi M, Karimi M, Aghighi M. Haemophilia in the developing countries: the Iranian experience. Arch Med Sci 2010; 6, 1: 83-89.
175.Karimi M, Johari S, Cohan N. Attitude toward prenatal diagnosis for beta-thalassemia major and medical abortion in Southern Iran. Hemoglobin. 2010; 34(1):49-54.
176.Karimi M, Cohan N, Moosavizadeh K, Falahi MJ, Haghpanah S. Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experience. Pediatr Hematol Oncol. 2010 Apr; 27(3):205-11.
177.Karimi M, Haghpanah S, Amirhakimi A, Afrasiabi AR, et al. Spectrum of inherited bleeding disorders in southern Iran, before and after the establishment of comprehensive coagulation laboratory. Blood Coagulation and Fibrinolysis 2009,20:642-645
178.Karimi M. Hydroxyurea in the management of thalassemia intermedia. Hemoglobin. 2009; 33 Suppl 1:S177-82.
179.Karimi M, Afrasiabi A, Amoei S, et al. Goagulation disorder in women with idiopathic menorrhagia. APJOH 2010; 2(1), February.
180.Taher AT, Musallam KM, Karimi M, El-Beshlawy A, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication-rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2009 Dec 23.
181.Rashid M, Majid OB, Dehghani M, Karimi M. Normal hemoglobin and hematological indices in Southwest of Iran. IJBC Vol 1, No 3, Spring 2009, 99-101.
182.Yavarian M, Shahian M, Karimi M, Rezaie N. Prevalence of pyruvate kinase deficiency among the newborns (Shiraz-Iran). IJBC Vol 1, No 3, Spring 2009, 89-93.
183.Yavarian M, Karimi M, Paran F, et al. Multi centric origin of Hb D-Punjab [beta 121 (CH4) Glu--> Gln, GAA>CAA]. Hemoglobin. 2009, 33(6):399-405.
184.Eshghi P, Mahjour SB, Naderi M, Dehbozorgian J, Karimi M. Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran. Haemophilia. 2010,16(2):38
185.Yavarian M, Saberfiroozi M, Mehrabani D, Amirizadeh S, Karimi M.  Prevalence of the HFE gene mutation in the liver transplanted and primary hemochromatosis patients in the Southern Iran. IRCMJ 2010; 12(1):22-26.
186.Zekavat OR, Mohammadi Samani S, Nasibi S, Karimi M. Clinical evaluation of the new topical anesthetic formulation in β-thalassemia major patients. The Journal of Applied Research Vol. 9, No. 3, 2009.
187.Karimi M, Cohan N, Zareifar S, et al. Initial presentation of childhood keukemia with facial palsy: three case reports. BMJcasereports 2009; Dec.
188.Taban S, Fotouhi Ghiam A, Mosallaei A, Bordbar MR, Mannucci PM, Karimi M. Frequency of antiphosholipid antibodies in Iranian patients with solid malignancies: a pilot study. Iran J Immunol. 2009 Sep; 6(3):160-2.
189.Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S. Effect of combination therapy of hydroxyurea with L- carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. Eur J Haematol. 2010 Jan 1; 84(1):52-8.
190.Roozbeh J, Sharifian M, Karimi M, Hamidian Jahromi AR, Afshariani R. Effect of zinc supplementation on red blood cell osmotic fragility in hemodialysis patients. Shiraz E Medical Journal. 2009 Oct; Vol. 10, No. 4
191.Lotfi M, Keramati P, Assdsangabi R, Nabavizadeh SA, Karimi M. Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran. Med Sci Monit. 2009 Aug;15(8):CR398-402
192.Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb hemost. 2009 Jun;35(4):426-38
193.Geramizadeh B, Banani A, Foroutan H, Aminsharifi A, Karimi M. Malignant epithelioid hemangioendothelioma of the bladder: the first case report in a child. J Pediatr Surg. 2009 Jul;44(7):1443-5
194.Karimi M, Giti R, Haghpanah S, Azarkeivan A, Hoofar H, Eslami M. Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: A multicenter study in Iran. Pediatr Blood Cacer. 2009, Dec.
195.Beheshtipour N, Cohan N, Karimi M. Home therapy and the effect of educational programmes in Iran; an alternative treatment option in developing countries. Haemophilia. 2009 May 19.
196.Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial. Fundam Clin Pharmacol. 2009 Jun; 23(3):359-65.
197.Mehrabani D, Pasalar M, Afrasiabi A.R, Mehravar Z, Reyhani I, Hamidi R, Karimi M. Frequency of thalassemia, Iron and Glucose-6-phosphate dehydrogenase deficiency among Turkish migrating nomad children in southern Iran. Acta Medica Iranica. 2009;Vol 47, No.1, 20-24
198.Zekavat OR, Karimi M, Rahmanian F. Is red cell from an otherwise healthy G6PD-deficient donor efficient for transfusion to fauvism patients? Indian J Hematol Blood Transfus. 2009 March;25(1):23-26
199.Rasekhi AR, Naderifar M, Bagheri MH, Shahriari M, Foroutan H, Karimi M, et al. Radiofrequency ablation of the spleen in patients with thalasemia intermedia: a pilot study. AJR Am J Roentgenol. 2009 May; 192(5):1425-9
200.Palla R, Lavoretano S, Lombardi R, Garagiola I, Karimi M, et al. The first delection mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura. Haematologica. 2009 Feb;94(2):289-93
201.Karimi M, Rasekhi AR, Rasekh M, Nabavizadeh SA, Assadsangabi R, Amirhakimi GH. Hypoparathyroidism and intracerebral calcification in patients with beta-thalassemia major. Eur J Radiol. 2009 Jun; 70(3):481-4.
202.Karimi M, Haghighat M, Moemen T, Jamalian N. Prevalence of Helicobacter pylori -associated peptic lesions among patients with sickle cell disease with recurrent abdominalpain. Indian J Gastroenterol. 2008 Sep-Oct; 27(5):213-4.
203.Karimi M, Bonyadi M, Galehdari MR, Zareifar S. Termination of pregnancy due to Thalassemia major, Hemophilia, and Down's syndrome: the views of Iranian physicians. BMC Med Ethics. 2008 Dec 23; 9(1):19.
204.Karimi M, Borzouee M, Mehrabani A, Cohan N. Echocardiographic finding in beta-thalassemia intermedia and major: Absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. Eur J Haematol. 2008 Dec 5.
205.Jafari H, Lahsaeizadeh S, Jafari P, Karimi M. Quality of life in thalassemia major: reliability and validity of the Persian version of the SF-36 questionnaire. J Postgrad Med. 2008 Oct-Dec;54(4):273-5
206.Karimi M, Cohan N, Bagheri MH, Lotfi M, Omidvari Sh, Gramizdeh B. A lump on the haead. Lancet. 2008 Oct 18; 372(9647):1436.
207.Gharagozloo M, Karimi M, Amirghofran Z. Double-faced cell-mediated immunity in beta-thalassemia major: Stimulated phenotype versus suppressed activity. Ann Hematol. 2009 Jan; 88(1):21-7.
208.Karamifar H, Karimi M, Sobhani N. Insulin-like growth factor-1 levels in children with Beta-thalassemia minor. Turk J Haematol. 2008 Sep.; 25 (3): 136-139
209.Karimi M, Jafari H, Lahsaeizadeh S, Afrasiabi A, Akbari A, Dehbozorgian J, Ardeshiri R, et al. Factor XI deficiency in Southern Iran: identification of a novel missense mutation. Annals of Hematolo 2009; 88 (4): 359-363
210.Tripodi A, Peyvandi F, Chantarangkul V, Palla R, Afrasiabi A, Canciani M.T, Chung D.W, Ferrari S, Fujimura Y, Karimi M, et al. Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13). Journal of Thrombosis and Hemostasis, 2008 (6): 1534-1541
211.Karimi M, Mehrabani D, Yarmohammadi H, Safaei Jahromi F. The prevalence of signs and symptoms of childhood leukemia and lymphoma in Fars Province, Southern Iran. Cancer Detect Prev. 2008; 32(2):178-83.
212.Karimi M.  Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath. Semin Hematol. 2008; 45 (SUPPL. 1): S74
213.Karimi M, Karamizadeh Z, Lahsaeizadeh S, Jafari H, Mavali Y, De Sanctis V. Prevalence of diabetic ketoacidosis (DKA) in thalassemia major patients in Iran due to secondary iron overload. Rivista Italiana di Medicina dell' Adolescenza – Volume 6, n. 1, April 2008, 47-51.
214.Karimi M, Lahsaeizadeh S, Jafari H, Salami Z. Evaluation of prevalence of drug dependence in beta-thalassemic patients and its risk factors.  Journal of substance Use. 2008; 13 (5): 293-298
215.Karimi M, Borhani Haghighi A, Yazdani M, Raisi H, Giti R, Namazee MR. Is b-thalassemia trait a protective factor against ischemic, cerebrovascular accidents? Journal of stroke and cerebrovascular diseases, Vol 17, No. 2,(March-April), 2008: 79-81
216.Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital Factor X deficiency. Haematologica. 2008; Haematologica 93 (6): 934-938
217.Karimi M, Shafieian R. Prophylactic effect of recombinant factor VIIa in two patients with congenital factor VII deficiency. Haemophilia. 2008 Jul; 14(4):851-2.
218.Karimi M, Rahmani S, Ardeshiri R, Pasalar M. Health status in Iranian haemophilic patients. Haemophilia. 2008; Haemophilia 14 (3): 615-617 
219.Karimi M, Jamalian N. Sociocultural challenges of thalassemia birth in Islamic and developing countries. J Pediatr Hematol Oncol, 2008 Apr; 30(4):335.
220.Derakhshan A, Karimi M, Ghadimi Moghadam A. Comparative evaluation of renal findings in Beta-thalassemia major and intermedia. Saudi J Kedney Dis Transpl 2008; 19(2):206-209.
221.Kashef S, Karimi M, Amirghofran Z, Ayatollahi M, et al. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int. Jnl. Lab. Hem. 2008; 30: 11-16.
222.Peyvandi F, Lavoretano S, Palla R, Feys H.B, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani M.T, Fabris F, Zver S, Reti M, Mikovic D, Karimi M, et al. Adamts13 and anti-adamts13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 2008 Feb;93(2):232-9
223.Karimi M, Yavarian M, Afrasiabi A, Dehbozorgian J, Rachmilewitz E. Prevalence of beta-Thalassemia Trait and Glucose-6-Phosphate Dehydrogenase Deficiency in Iranian Jews. Arch Med Res. 2008 Feb; 39(2):212-4.
224.Inaloo S, Karimi M. Facial palsy as first presentation of acute lymphoblastic leukemia: A case report. Iran J Child Neurology. 2007 Nov;2(1):51-53  
225.Karimi M, Bagheri MH, Tahmtan M, Shakibafard A, Rashid M. Prevalence of hepatosplenomegaly in beta thalassemia minor subjects in Iran. 2009; European Journal of Radiology 69 (1): 120-122.
226.Yavarian M, Karimi M, Shahriary M, Afrasiabi AR. Prevalence of pyruvate kinase deficiency among the south Iranian population: Quantitative assay and molecular analysis.Blood Cells Mol Dis. 2008; Blood Cells, Molecules, and Diseases 40 (3): 308-311
227.Kadivar MR, Ghaneh-Shirazi R, Khavandegaran F, Karimi M. Epidemiology of tuberculosis among Afghan immigrants in Fars province, Southern Islamic Republic of Iran. East Mediter Health J. 2007 Jul-Aug; 13(4):758-64.
228.Karimi M, Nikrooz P, Kashef S, Jamalian N, Davatolhagh Z. RBC alloimmunization in blood transfusion dependent beta-thalassemia patients in Southern Iran. Int J Lab Hematol. 2007 Oct; 29(5):321-6
229.Afrasiabi A, Lecchi A, Artoni A, Karimi M, Ashouri E, Peyvandi F, Mannucci PM. Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran. Platelets. 2007 Sep; 18(6):409-13
230.Karimi M, Khanlari M, Rachmilewitz EA. Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI). 2008; American Journal of Hematology 83 (1): 77-79
231.Bazrgar M, Karimi M, Fathzadeh M, Senemar S, Peiravian F, Shojaee A, Saadat M. Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts. Mol Biol Rep. 2008; 35 (4): 495-499
232.Karimi M. Bone mineral density and thalassemia-reply. Indian Pediatr. 2007 Jul; 44(7):550
233.Karimi M, Borhani Haghighi A, Raisi H, Yazdani M, Namazi MR. Is b-thalassemia trait a protective factor against ischemic cerebrovascular attacks? Scientific Medical Journal. Ahwaz Jundishapur University of Medical Sciences. Winter 2007;51 (4-5):753-756
234.Sabzi A, Karimi M. A 13-year study on the prevalence and clinical features of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in patients referring hospitals to Shiraz University. Scientific Medical Journal. Ahwaz Jundishapur University of Medical Sciences. 2007 Spring; 52(1-6):16-24
235.Akbari A, Imanieh MH, Karimi M, Tabatabaee HR. Hepatitis C virus antibody positive cases in multitransfused thalassemic patients in South of Iran. Hepatitis Monthly 2007; 7(2): 63-66
236.Karimi M, Hashemi A, Ghiam AF, Jahromi SS, Toobaee S. Substance dependency in Iranian patients with hemophilia. Addict Behav. 2007 Feb; 32(2):365-9
237.Karimi M, Rahmani S, Ardeshiri R, Rahman Attar A, Pasalar M. Cost of care in Iranian hemophilic patients. IRCMJ, 2007; 9(3):1561-4395
238.Bazrgar M, Karimi M, Peiravian F, Fathzadeh M, Fattahi MJ. Apolipoprotein E4 allele and the risk of left ventricular dysfunction in thalassemia major. Iranian Cardiovascular Research Center. 2007; 1(1):13-19
239.Foroughinia F, Karimi M. The protective effects of ginkgo biloba extract in decreasing hemolysis of RBC in glucose-6-phosphate dehydrogenase-deficient patients. J Pediatr Hematol Oncol. 2007 Jul; 29(7):511-512
240.Karimi M, Jamalian N, Rasekhi A, Kashef S. Magnetic resonance imaging (MRI) findings of joints in young b-thalassemia major patients. Fluid surrounding the scaphoid bone. J Pediatr Hematol Oncol 2007 June; 29(6):393-8
241.Monaldini L, Asselta R, Duga S, Peyvandi F, Karimi M, Malcovati M, Tenchini ML. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects. Thromb Haemost. 2007 Apr;97(4):546-51
242.Bazrgar M, Karimi M, Peiravian F, Fathzadeh M. Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia major. Haematologica. 2007 Feb;92(2):256-7
243.Karimi M, Ghiam AF, Hashemi A, Alinejad S, Soweid M, Kashef S.

Bone mineral density in beta-thalassemia major and intermedia. Indian Pediatr. 2007 Jan;44(1):29-32
244.Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A. Premarital screening for b-thalassemia in southern Iran: options for improving the programme. J Med Screen 2007; 14: 62-66
245.Karimi M, Yarmohammadi H, Cappellini MD. Analysis of intelligence quotient in patients with homozygous beta-thalassemia. Saudi Med J. 2006 Jul; 27(7): 982-5
246.Yavarian M, Farshidfar GR, Karimi M, Almoazzez M, Harteveld CL, Giordano PC. Survival analysis of transfusion dependent b-thalassemia major patients. J Res Health Sci. 2006; 6(2):8-13
247.Karimi M, Zekavat OR, Sharifzadeh S, Mosavizadeh K. Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray. Am J Hematol. 2006 Aug; 291(1):35-9.
248.Karimi M, Sabzi A, Peyvandi F, Mannucci P.M. Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in Southern Iran. Intern Emerg Med. 2006;1(1):35-39
249.Marvasti VE, Dastoori P, Karimi M. Is beta-thalassemia trait a risk factor for developing depression in young adults? Ann Hematol. 2006 Dec; 85(12):873-4
250.Shahian M, Zekavat O, Karimi M. Extensive thrombosis following central venous catheterization in a neonate with homozygous protein C deficiency presenting purpura fulminans. Care Rep Clin Pract Rev. 2006;7: 107-110
251.Karamifar H, Karimi M, Amirhakimi GH, Badiei M. Endocrine function in thalassemia intermedia. IJBS Vol 2, No 3, September 2006: 236-240
252.Nabavizadeh S.H, Karimi M, Amin R. Cutaneous finding in anti thymocyte globulin induced serum sickness. Iran J Allergy Asthma Immunol. 2006 March;5(1):39-40
253.Pishva N, Karimi M. A pilot study on the rate of hemoglobinopathies in hyperbilirubinemic term neonates at Nemazee hospital Shiraz, Iran. Journal of Shaheed Sadoughi University of Medical Sciences and Health Services. Winter 2006;13(5):15-18
254.Bazrgar M, Karimi M. Frequency of apolipoprotein E alleles in Iranian populations. Iranian journal of biotechnology, Vol. 4, No. 2, April 2006: 141
255.Imanieh MH, Mowla A, Zohouri D, Forootan HR, Karimi M. Spontaneous perforation of the common bile duct with eosinophilia in an 18-month-old girl: A case report and review of literature. Med Sci Monit. 2006 Mar;12(4):31-33
256.Karimi M, Sabzi A, Peyvandi E, Mannucci PM. Changing epidemiology of the hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in southern Iran. J Thromb Haemost. 2006 Mar;4(3):701-2
257.Karimi M, Garagiola M.B, Sharif Kazemi S., et al. Molecular study of vascular endothelial growth factor gene in Iranian patients after myocardial infarction. IJMS. 2006 March; 31(1): 1-4
258.Kashef MA, Kashef S, Handjani F, Karimi M. Hodgkin lymphoma developing in a 4.5 year-old girl with hyper-IgE syndrome. Pediatr Hematol Oncol. 2006 Jan-Feb; 23(1):59-63
259.Karimi M, Marvasti VE, Motazedian S, Sharifian M. Is beta-thalassemia trait a protective factor against hypertension in young adults? Ann Hematol. 2006 Jan; 85(1): 29-31. 
260.Karimi M, Panahande A, Afrasiabi A. Evaluation of factor V leiden and prothrombin mutations in South of Iran. ARMAGHANDANESH.Winter 2006; 11(4):81-88.
261.Amin A, Jalali S, Amin R, Aale-yasin S, Jamalian N, Karimi M. Evaluation of the serum levels of immunoglobulin and complement factors in b-thalassemia major patients in Southern Iran. Iranian Journal of Immunology. 2005;2(4): 221-226
262.Karimi M, Imanieh MH, Ghiam A, Hashemi Z. Investigation of helicobacter pylori infection in b-thalassemia major patients with recurrent abdominal pain. European Journal of Gastroenterology & Hepatology. 2005 Dec.; 17(12):1363-7.
263.Afrasiabi A, Artoni A, Karimi M, Peygandi F, et al. Glanzmann thrombasthenia and Bernard-Soulier syndrome in South Iran. Clin Lab Hematol. 2005 Oct; 27(5):324-7.
264.Karimi M, Darzi H, Yavarian M. Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol. 2005 Jul;27(7):380-5
265.Yavarian M, Karimi M, Zorai A, et al. Molecular basis of Hb H disease in southwest Iran. Hemoglobin. 2005; 29(1): 43-50
266.Momen T, Karimi M, Haghighat H. Role of helicobacter pylori infection in sickle cell disease with recurrent abdominal pain. Armaghane-danesh. 2005 Autumn; 10(3): 35-40 
267.Asadipooya A, Karamizadeh Z, Bagheri MH, Rasekhi A, Karimi M, et al. Radiologic findings of childhood acute lymphoblastic leukemia during and after chemotherapy. Ahwaz Jundishapur University of Medical Sciences. Summer 2005; 4(2): 123-126
268.Geramizadeh B, Daneshbood Y, Karimi M. Cytology of brain metastasis of yolk sac tumor. Acta Cytol. 2005 Jan-Feb; 49(1):110-1
269.Yavarian M, Sharifi S, Harteveld Cl, Giordano PC, Karimi M. The haemoglobin O-Indonesia in South of Iran: a case report and review of literature. Haema 2005; 8(1): 129-132
270.Mowla A, Karimi M, Afrasiabi A, De Sanctis V. Prevalence of diabetes mellitus and impaired glucose tolerance in beta thalassemia patients with and without hepatitis C virus infection. Pediatric Endocrinology Reviews (Supplement). 2004 Dec; 2(2):282-4.
271.Karamifar H, Karimi M, Amirhakimi GH, et al. Reduced insulin growth factor I concentrations in iron-overloaded b thalassemic patients with normal growth hormone secretion and liver function. Pediatric Endocrinology Reviews (Supplement). 2004 Dec;2(2):   256-8.
272.Karimi M, Yavarian M, Delbini P, et al. Spectrum and haplotypes of the HFE hemochromatosis gene in Iran: H63D in beta-thalassemia major and the first E277K homozygous.  Hematol J. 2004;5(6):524-7.
273.Enayat MS, Karimi M, Chana G, et al. Mutation analysis in f9 gene of 17 families with haemophilia B fror Iran. Haemophilia. 2004 Nov; 10(6): 751-5.
274.Castelli R, Graziadei G, Karimi M, et al. Intrathoracic masses due to extramedullary hematopoiesis. Am J Med Sci. 2004 Nov; 328(5):299-303.
275.Karimi M, Karamifar H. Short stature in Beta thalassemia minor subjects in Iran. Med Sci Monit. 2004 Oct 26; 10(11): 603-605.  
276.Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. Haematologica. 2004 Oct; 89(10): 1172-8.
277.Karimi M, Zakerinia M, Khojasteh HN, Ramzi M, et al. Successful treatment of recombinant factor VIIa in hemorrhagic cystitis induced by cyclophosphamide in post bone marrow transplantation. J Thromb Haemost. 2004 Oct; 2(10): 1853-5.
278.Bazrgar M, Peiravian F, Karimi M, Fathzadeh M. Correlation between left ventricular dysfunction with hematological parameters and Iron chelation in b-thalassemia major. JMR. Autumn 2004; 3(1): 48-58
279.Menegatti M, Karimi M, Garagiola I, Mannucci P, et al. A rare inherited coagulation disorder: Combined homozygous factor VII and factor X deficiency. Am J Hematol. 2004 Sep; 77(1): 90-1.
280.Karimi M, Peyvandi F, Siboni S, Ardeshiri R, Gringeri A, Mannucci PM. Comparison of attitudes towards prenatal diagnosis and termination of pregnancy for haemophilia in Iran and Italy. Haemophilia. 2004 Jul; 10(4):367-9.
281.Alborzi A, Cheriki S, Karimi M, Kalani M, Aboodi B. Survey incidence rate of bacterial infection in febrile neutropenic patient (under 15) admitted in Shiraz Medical Hospital (1379-1380). Iranian Journal of Infectious Diseases and Tropical Medicine. 2004; 9(24):6-9.
282.Asadi-pooya AA, Karimi M, Imanieh MH. Growth retardation in children with thalassemia major. Haema 2004; 7(4): 493-496.
283.Alavi M, Nabavizadeh A, Mowla A, Karimi M. Bone scintigraphy in acute lymphoblastic leukemia. IJMS. 2004 June; 29(2), 14-16.
284.Karimi M, Mosallanejad L, Abdolahifard M. Liver enzyme assessment in thalassemia major patients who underwent bone marrow transplantation, Shiraz 2002. JMR. Spring 2004; 2(3): 62-70
285.Peyvandi F, Tagliabue L, Menegatti M, Karimi M, Komaromi I, Katona E, Muszbek L, Mannucci PM. Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat. 2004 Jan; 23(1):98.
286.Asadipooya S, Karamizadeh Z, Rahiminejad MR, Shahriari M, Karimi M. Calcium metabolism disorders in childhood acute lymphoblastic lymphoma, before and after chemotherapy. Iranian Journal of Endocrine and metabolism. 2003; 5(2):211-214.
287.Pasalar M, Mojarrab M, Rasekhi AR, Afrasiabi A, Yazdanpanah F, Karimi M. Childhood Neuroblastoma: A 10-Years Study (1991-2001). Journal of Medical Research. 2003; 1(4):25-33.
288.Rahimi Z, Karimi M, Haghshenass M, Merat M. b-Globin gene cluster haplotypes in sickle cell patients from Southwest Iran. American Journal of Hematology. 2003;74:156-160
289.Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracerebral calcification in patients with beta-thalassemia major. J Pediatr Endocirinol Metab 2003 Jul-Aug; 16 (6): 883-6
290.Karimi M, Yarmohammadi H. Seasonal variation in the onset of childhood leukemia /lymphoma, 1996 to March 2000, Shiraz, Iran. Hematol Oncol. 2003 Jun; 21 (2):51-5
291.Mannucci PM, Karimi M, Mosalaei A, Canciani MT, Peyvandi F. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). Haematologica. 2003 Apr; 88(4): 454-8
292.Karimi M, Martinez Di Montemuros F, Danielli MG, Farjadian S, Afrasiabi A, Fiorelli G, Cappellini MD. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Fars province of Iran. Haematologica, 2003 Mar; 88(3): 346-7.
293.Kadivar MR, Yarmohammadi H, Mirahmadizadeh AR, Vakili M, Karimi M. Prevalence of iron deficiency anemia in 6 months to 5 years old children in Southern Iran. Med Sci Monit. 2003 Feb; 9(2): 100-4.
294.Karimi M, Yarmohammadi H, Sabri MR. An analysis of prognostic factors and the five-year survival rate in children with lymphoblastic leukemia. Med Sci Monit. 2002 Dec; 8(12): 792-6.
295.Payvandi F, Spreafico M, Karimi M, Zeinali S, Mannucch PM. Allele frequency of CYP2C9 polymorphisms in Iran. Thromb Haemost 2002;88:874-5
296.Karimi M, Rasekhi AR. Efficiency of premarital screening of beta- thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. Haematologia (Budap) 2002;32(2):129-33
297.Karimi M, Yarmohammadi H, Ardeshiri R. Inherited coagulation disorders in Southern Iran. Haemophilia 2002 Nov; 8(6):740-4
298.Kumar PV, Karimi M, Monabbati A, et al.: Cytology of leukemic lymphadenopathy. Acta Cytol 2002 Sep-Oct;46(5):801-7
299.Karimi A, Nategian A, Karimi M, Shirvani B. Correlation between acute phase inflammation markers with cardiac complications in patients with Kawasaki disease. Journal of Hamedan University of Medical Sciences. Autumn 2002; 9(3): 17-21
300.Karimi M, Asadipooya A, Khademi B, et al: Evaluation of the incidence of sensory – neural hearing loss in Beta – thalassemia major patients under regular chelation therapy with desferrioxamine. Acta Haematol. 2002; 108(2):79-83.
301.Karimi M, Yarmohammadi H, Ghavanini A, Kumar P. Epidemiological surveillance of pediatric Hodgkin s disease in Southern Iran. Med Sci Monit. 2002 Aug;8(8):572-5
302.Kumar PV, Moosavi A, Karimi M, Bedayat GR: Fine needle aspiration of Langerhans cell histiocytosis of the lymph nodes. A report of six cases. Acta Cytol. 2002 Jul-Aug;46(4):753-6
303.Karimi M, Yarmohammadi H, Zeinali S, et al: Beta thalassemia intermedia from Southern Iran: IVS- II- I (G® A) is the prevalent thalassemia intermedia Allele. Hemoglobin 2002 May;26(2):147-54
304.Karimi M, Kadivar R, Yarmohammadi H. Assessment of the prevalence of iron deficiency anemia, by serum ferritin, in pregnant women of Southern Iran. Med Sci Monit 2002 Jul;8(7):488-92
305.Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused children in Shiraz – Iran. J Pediatr Child Health 2001 Dec;37(6):564-6
306.Karimi M, Ghavanini AA: Seroprevalence of HBsAg, anti-HCV, and anti-HIV
Among haemophiliac patients in Shiraz, Iran. Haematologica (Budap). 2001; 31(3): 251 – 5
307.Kumar PV, Moosavi A, Karimi M, et al.: Subclassification of Localized leishmania lymphadenitis in FNA semears. Acta Cytologica, 2001 Jul - Aug; 45 (4): 547 – 54
308.Karimi M, Ghavanini AA, Kadivar MR: Regional mapping of the gene frequency of b- thalassemia in Fars Province, Iran during 1997 – 1998. Irn J Med Sci 2000; 25 (3&4): 134 – 137
309.Pedram M, Zandian KM, Kiekhaie B, Mosawai F and Karimi M: Children clinical oncology emergency with 14 case reports of vencava and mediastinum syndromes in Ahwaz. Scientific Med J Ahwaz Univ Med Sci 1998; 23: 69 – 83

مركز تحقيقات هماتولوژی
دانشگاه علوم پزشكی شيراز
نشانی: شیراز - خیابان خلیلی-برج تحقیقات محمد رسول الله-طبقه ششم-مرکز تحقیقات هماتولوژی 
تلفن های تماس: 07136122263-07136281528
فاکس: 07136281563
پست الکترونیک:

کارگاه ها و همایش ها
EHA meeting in Shiraz
سمینار تازه های تالاسمی

20 و 21 اردیبهشت 97 

آئین نامه ها و فرم ها

تازه های سایت